MedTrace Logo

Clinical Trial On The Effect Of Artisterol On Risk Factors In Individuals With Suboptimal Cholesterol Levels

NCT07405814 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2026-05-12

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if Artisterol works to lower LDL cholesterol and other metabolic and vascular risk factors in adults. The main questions it aims to answer are:

• Does Artisterol lower low-density lipoprotein cholesterol (LDL-C) levels in participants and by how much? Researchers will compare Artisterol to a placebo (a look-alike substance that contains no drug) to see if Artisterol works to lower LDL cholesterol.

Participants will:

* Take drug Artisterol or a placebo every day for 3 months
* Visit the clinic once every 6 weeks for checkups and tests
* Keep a diary of their Artisterol intake and physical activity

Conditions

  • Hyperlipoproteinemia

Interventions

DIETARY_SUPPLEMENT

investigational product containing phytosterol, artichoke extract and thiamin

subjects will take the investigational product once daily

OTHER

Placebo

matching placebo administration

Sponsors & Collaborators

  • Zentiva, k.s.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-24
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07405814 on ClinicalTrials.gov